79491-08-0

Basic information

• Product Name: dimethyl 2-(3,7,11-trimethyldodeca-2,6,10-trienyl)malonate
• CAS NO: 79491-08-0
• Molecular Weight: 336.472
• Mol File: 79491-08-0.mol

Chemical Properties

• CAS DataBase Reference: dimethyl 2-(3,7,11-trimethyldodeca-2,6,10-trienyl)malonate(CAS DataBase Reference)
• NIST Chemistry Reference: dimethyl 2-(3,7,11-trimethyldodeca-2,6,10-trienyl)malonate(79491-08-0)
• EPA Substance Registry System: dimethyl 2-(3,7,11-trimethyldodeca-2,6,10-trienyl)malonate(79491-08-0)

Safety Data

• Hazardous Substances Data: 79491-08-0(Hazardous Substances Data)

Upstream product

• 488115-81-7 (2E/Z,6E)-farnesyl bromide 
• 108-59-8 malonic acid dimethyl ester 
• 111074-88-5 (6E,10E)-methyl 2,7,11,15-tetramethyl-3-oxohexadeca-6,10,14-trienoate 
• 1117-52-8 6,10,14-trimethyl-5,9,13-pentadecatriene-2-on 
• 106-28-5 Farnesol 
• 24163-93-7 farnesyl bromide 
• 10154-05-9 Methyl 4-trans-8-trans-farnesylacetat 
• 616-38-6 carbonic acid dimethyl ester 
• 111074-87-4 (6E,10E)-methyl 7,11,15-trimethyl-3-oxohexadeca-6,10,14-trienoate 

Downstream Products

• 203985-85-7 (4R,2'S,5'E,9'E)-3-(1'-Oxo-2'-prop-2''-enyl-6',10',14'-trimethylpentadeca-5',9',13'-trienyl)-4-benzyloxazolidin-2-one 
• 203985-84-6 (4R,5'E,9'E)-3-(1'-Oxo-6',10',14'-trimethylpentadeca-5',9',13'-trienyl)-4-benzyloxazolidin-2-one 
• 197590-02-6 (4S,2'R,5'E,9'E)-3-(1'-Oxo-2'-prop-2''-enyl-6',10',14'-trimethylpentadeca-5',9',13'-trienyl)-4-benzyloxazolidin-2-one 
• 197590-01-5 (4S,5'E,9'E)-3-(1'-Oxo-6',10',14'-trimethylpentadeca-5',9',13'-trienyl)-4-benzyloxazolidin-2-one 
• 10154-05-9 Methyl 4-trans-8-trans-farnesylacetat 

Relevant articles and documents

Towards the synthesis of bisubstrate inhibitors of protein farnesyltransferase: Synthesis and biological evaluation of new farnesylpyrophosphate analogues

Protein farnesyltransferase (FTase) has recently appeared as a new target of parasitic diseases, a field poor in drugs in development. With the aim of creating new bisubstrate inhibitors of FTase, new farnesyl pyrophosphate analogues have been studied. Fa

Synthesis of rac-hippospongic acid A and revision of the structure

rac-Hippospongic acid A of the reported structure 1 and the revised structure 2 were synthesized. The synthetic strategy of these compounds consists of homologation of (2E,6E,10E)-geranylgeraniol and (2E,6E)-farnesol, respectively, Wadsworth-Emmons reaction, and cyclization to form the tetrahydropyran ring bearing an α-methylene group on the carboxylic moiety. Spectral comparisons of the synthetic compounds 1,2 and the natural product suggested that hippospongic acid A bears the structure of 2.

Stereoselective syntheses of (+)-rhopaloic acid A and (-)-ent- and (±)-rac-rhopaloic acid A

Rhopaloic acid A (+)-1 and the related compounds (-)-ent-1 and (±)-rac-1 have been stereoselectively synthesized. The synthetic strategy consists of successive homologation of (2E,6E)-farnesol 7 and cyclization to form a tetrahydropyran ring, together wit

Synthesis of norsesterterpene rac- and ent-rhopaloic acid A

The stereoselective synthesis of rac- and ent-rhopaloic acid A 1 has been accomplished, via successive homologation of (2E,6E)-farnesol 2 and cyclization to form a tetrahydropyran ring, together with final introduction of an α-methylene group; the asymmet

Stereochemical Studies on Porphyrin a: Assignment of the Absolute Configuration of a Model Porphyrin by Degradation

The synthesis is described of a porphyrin alcohol (22) which has a structure very similar to that of porphyrin a (2).The model porphyrin was resolved by separation of its camphanate esters.Ozonolysis of the 2-nitrobenzoate of each enantiomer in tritiated form gave a derivative of 2-hydroxypentadioic acid whose configuration was determined by dilution analysis.It is demonstrated that correlation of the stereochemistry of porphyrin a with that of the model (22) will be possible by means of the (1)H and (19)F n.m.r. spectra of the corresponding esters with (-)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoic acid.